Global Non-Invasive Prenatal Testing (NIPT) Pipeline Market Report 2022: Benchmarking at Different Stages of Development and Information on Ongoing Clinical Trials –

DUBLIN–(BUSINESS WIRE)–The report “Non-Invasive Prenatal Testing (NIPT) Pipeline including Development Stages, Segments, Region & Countries, Regulatory Pathway and Key Companies, 2022 Update” has been added to from offer.

The report provides comprehensive information about the products in the Non-Invasive Prenatal Testing (NIPT) pipeline with a comparative analysis of products at different stages of development and information about ongoing clinical trials.


  • Extensive coverage of non-invasive prenatal testing (NIPT) under development

  • The report examines details of major pipeline products including product description, licensing and collaboration details and other development activities.

  • The report reviews key players involved in the development of Non-Invasive Prenatal Test (NIPT) and lists all their pipeline projects

  • Pipeline product coverage based on various stages of development ranging from early development stage to approved/released stage

  • The report provides key clinical trial data from ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to buy

  • Formulate important competitor information, analysis and insights to improve R&D strategies

  • Identify emerging players with a potentially strong product pipeline and create effective counter-strategies to gain competitive advantage

  • Identify and understand the important and diverse types of non-invasive prenatal testing (NIPT) under development

  • Develop market entry and expansion strategies

  • Effectively plan mergers and acquisitions by identifying key players with the most promising pipeline

  • In-depth analysis of current product development stage, territory and estimated launch date

Main topics covered:

1 Table of Contents

1.1 List of tables

1.2 List of Figures

2 Presentation

2.1 Presentation of the non-invasive prenatal test (NIPT)

3 products in development

3.1 Non-Invasive Prenatal Testing (NIPT) Pipeline Products by Development Stage

3.2 Non-Invasive Prenatal Testing (NIPT) Pipeline Products by Territory

3.3 Non-Invasive Prenatal Testing (NIPT) – Pipeline Products by Regulatory Route

3.4 Non-Invasive Prenatal Testing (NIPT) Pipeline Products by Estimated Approval Date

3.5 Non-Invasive Prenatal Testing (NIPT) – Ongoing Clinical Trials

4 Non-Invasive Prenatal Screening (NIPT) – Products Under Development by Companies

4.1 Non-Invasive Prenatal Testing (NIPT) Businesses – Pipeline Products by Development Stage

4.2 Non-Invasive Prenatal Testing (NIPT) Pipeline Products by Development Stage

5 Non-Invasive Prenatal Screening (NIPT) Companies and Product Overview

5.1 Agena Bioscience Inc Company Overview

5.2 Amity University Company Overview

5.3 Presentation of BCML GmbH

5.4 BioCeps Company Overview (inactive)

5.5 Biocept Inc Company Overview

5.6 Biofidelity Ltd Company Overview

5.7 BioFluidica Microtechnologies LLC Company Overview

5.8 Cardiff Oncology Inc Company Overview

5.9 Celula Inc Company Overview

5.10 ChromaCode Inc Company Overview

5.11 Echelon Diagnostics Inc Company Overview

5.12 Elysium Health Inc Company Overview

5.13 Fluxion Biosciences Inc Company Overview

5.14 Helicos BioSciences Corporation Company Overview

5.15 Illumina Inc Company Overview

5.16 INEX Innovate Pte Ltd Company Overview

5.17 Johns Hopkins University Business Overview

5.18 Juno Diagnostics Inc Company Overview

5.19 KellBenx Inc Company Overview (Inactive)

5.20 Business overview of Université Laval

5.21 Maastricht University Medical Center Company Overview

5.22 Natera Inc Company Overview

5.23 Oxford Gene Technology Ltd Company Overview

5.24 PerkinElmer Inc Company Overview

5.25 Presentation of Sequenom Inc.

5.26 Standard BioTools Inc Company Overview

5.27 StellarGene Technologies Pvt Ltd Company Overview

5.28 Chaim Sheba Medical Center Company Introduction

5.29 Chinese University of Hong Kong Society Overview

5.30 Presentation of thromboDx BV

5.31 Tufts Medical Center Company Overview

5.32 Oxford University Business Overview

6 Appendix

For more information about this report visit

Source link

Comments are closed.